ANXA1 and infection: This combination brings us to a new treatment strategy that eliminate mtFPs and/or supplement with ANXA1-mimetic peptides might be a useful attempt to improve the complex anti-infection situations, which may be beneficial to clinical pathogen infection control and reduce the mortality rate in severe septic patients.